Literature DB >> 9288148

Hemodynamic alteration by fetal surgery accelerates myocyte proliferation in fetal guinea pig hearts.

Y Saiki1, A Konig, J Waddell, I M Rebeyka.   

Abstract

BACKGROUND: Fetal heart development occurs by hyperplasia as myocytes lose the capacity to proliferate at birth. This potential for cell division may have application in altering fetal growth patterns in congenital cardiac malformations, but it is not known whether the proliferative activity can be modified by intrauterine surgical manipulation. The purpose of this study was to determine whether hemodynamic alteration by fetal surgery influences myocyte proliferation and myocardial development.
METHODS: Six pregnant guinea pigs of 50 to 52 days of gestation (term, 65 days) underwent hysterotomy, and the fetal ascending aorta was banded and narrowed by 50% (AoB). Cesarean section was performed near term, and the heart was assessed for myocyte proliferative activity (Ki-67 monoclonal antibody), apoptosis, and morphologic features.
RESULTS: The heart to body weight ratio (1.02% +/- 0.12% versus 0.42% +/- 0.02%, p < 0.01) and left ventricular posterior wall thickness (1.89 +/- 0.25 mm versus 1.31 +/- 0.19 mm, p < 0.01) were significantly higher in the AoB group. The percentage of Ki-67 positive cells was increased in AoB group (29.5% +/- 4.4% versus 15.3% +/- 1.3% in right ventricle, 35.8% +/- 5.1% versus 13.1% +/- 1.7% in interventricular septum, and 39.8% +/- 3.2% versus 12.0% +/- 2.0% in left ventricle (p < 0.01). The apoptotic cell to myocyte ratio was less than 1/1000 in both groups.
CONCLUSIONS: Fetal hemodynamic alteration by aortic banding accelerates myocardial cellular proliferation without affecting apoptosis, suggesting that in utero cardiac interventions have a greater influence on myocardial development compared with postnatal intervention.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9288148     DOI: 10.1016/s0039-6060(97)90034-9

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  15 in total

1.  Engineered fetal cardiac graft preserves its cardiomyocyte proliferation within postinfarcted myocardium and sustains cardiac function.

Authors:  Kazuro L Fujimoto; Kelly C Clause; Li J Liu; Joseph P Tinney; Shivam Verma; William R Wagner; Bradley B Keller; Kimimasa Tobita
Journal:  Tissue Eng Part A       Date:  2011-01-16       Impact factor: 3.845

Review 2.  Fetal programming as a predictor of adult health or disease: the need to reevaluate fetal heart function.

Authors:  Joana O Miranda; Carla Ramalho; Tiago Henriques-Coelho; José Carlos Areias
Journal:  Heart Fail Rev       Date:  2017-11       Impact factor: 4.214

3.  Calcium signaling regulates ventricular hypertrophy during development independent of contraction or blood flow.

Authors:  Nicholas D Andersen; Kapil V Ramachandran; Michelle M Bao; Margaret L Kirby; Geoffrey S Pitt; Mary R Hutson
Journal:  J Mol Cell Cardiol       Date:  2014-12-20       Impact factor: 5.000

Review 4.  Myocyte proliferation in the developing heart.

Authors:  David Sedmera; Robert P Thompson
Journal:  Dev Dyn       Date:  2011-05-02       Impact factor: 3.780

5.  A proliferative burst during preadolescence establishes the final cardiomyocyte number.

Authors:  Nawazish Naqvi; Ming Li; John W Calvert; Thor Tejada; Jonathan P Lambert; Jianxin Wu; Scott H Kesteven; Sara R Holman; Torahiro Matsuda; Joshua D Lovelock; Wesley W Howard; Siiri E Iismaa; Andrea Y Chan; Brian H Crawford; Mary B Wagner; David I K Martin; David J Lefer; Robert M Graham; Ahsan Husain
Journal:  Cell       Date:  2014-05-08       Impact factor: 41.582

6.  Predictors of technical success and postnatal biventricular outcome after in utero aortic valvuloplasty for aortic stenosis with evolving hypoplastic left heart syndrome.

Authors:  Doff B McElhinney; Audrey C Marshall; Louise E Wilkins-Haug; David W Brown; Carol B Benson; Virginia Silva; Gerald R Marx; Arielle Mizrahi-Arnaud; James E Lock; Wayne Tworetzky
Journal:  Circulation       Date:  2009-09-28       Impact factor: 29.690

Review 7.  Building and re-building the heart by cardiomyocyte proliferation.

Authors:  Matthew J Foglia; Kenneth D Poss
Journal:  Development       Date:  2016-03-01       Impact factor: 6.868

8.  Chronic right ventricular pressure overload results in a hyperplastic rather than a hypertrophic myocardial response.

Authors:  Boudewijn P J Leeuwenburgh; Willem A Helbing; Arnold C G Wenink; Paul Steendijk; Roos de Jong; Enno J Dreef; Adriana C Gittenberger-de Groot; Jan Baan; Arnoud van der Laarse
Journal:  J Anat       Date:  2008-02-01       Impact factor: 2.610

9.  Engineered early embryonic cardiac tissue increases cardiomyocyte proliferation by cyclic mechanical stretch via p38-MAP kinase phosphorylation.

Authors:  Kelly C Clause; Joseph P Tinney; Li J Liu; Bradley B Keller; Kimimasa Tobita
Journal:  Tissue Eng Part A       Date:  2009-06       Impact factor: 3.845

10.  Human cardiomyopathy mutations induce myocyte hyperplasia and activate hypertrophic pathways during cardiogenesis in zebrafish.

Authors:  Jason R Becker; Rahul C Deo; Andreas A Werdich; Daniela Panàkovà; Shannon Coy; Calum A MacRae
Journal:  Dis Model Mech       Date:  2011-01-18       Impact factor: 5.758

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.